OTCPK:GRST

Stock Analysis Report

Executive Summary

Ethema Health Corporation, together with its subsidiaries, operates substance abuse treatment center.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Risks

  • Ethema Health has significant price volatility in the past 3 months.
  • Ethema Health is not covered by any analysts.

Share Price & News

How has Ethema Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-20.2%

OTCPK:GRST

0.8%

US Healthcare

1.3%

US Market


1 Year Return

-30.3%

OTCPK:GRST

-8.2%

US Healthcare

2.0%

US Market

GRST underperformed the Healthcare industry which returned -8.2% over the past year.

GRST underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

GRSTIndustryMarket
7 Day-20.2%0.8%1.3%
30 Day-16.4%-1.5%3.9%
90 Day-19.1%-0.5%3.4%
1 Year-30.3%-30.3%-6.8%-8.2%4.2%2.0%
3 Year49.5%49.5%30.2%24.9%47.2%37.6%
5 Year-45.0%-45.0%63.6%53.9%60.5%42.9%

Price Volatility Vs. Market

How volatile is Ethema Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Ethema Health undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Ethema Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Ethema Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of GRST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Ethema Health regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Ethema Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ethema Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of GRST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Ethema Health's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Ethema Health performed over the past 5 years?

-39.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Ethema Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Ethema Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Ethema Health's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Ethema Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Ethema Health has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Ethema Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Ethema Health's financial position?


Financial Position Analysis

Ethema Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Ethema Health's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Ethema Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Ethema Health's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

Ethema Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Ethema Health has less than a year of cash runway based on current free cash flow.

Ethema Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 42.4% each year.


Next Steps

Dividend

What is Ethema Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Ethema Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Ethema Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Ethema Health has not reported any payouts.

Unable to verify if Ethema Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Ethema Health has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Ethema Health's salary, the management and board of directors tenure and is there insider trading?

US$182k

CEO Compensation


CEO

Shawn Leon (60yo)

8.4yrs

Tenure

US$182,430

Compensation

Mr. Shawn E. Leon has been a Director of Ethema Health Corporation since November 29, 2010. He has been Greenesent of Ethema Health Corporation ((also known as Greenestone Healthcare Corporation, Nova Nat ...


CEO Compensation Analysis

Shawn's remuneration is lower than average for companies of similar size in United States of America.

Shawn's compensation has been consistent with company performance over the past year, both up more than 20%.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$2,24012 Dec 18
Shawn Leon
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares28,350
Max PriceUS$0.079

Ownership Breakdown


Management Team

  • Shawn Leon (60yo)

    Chairman

    • Tenure: 8.4yrs
    • Compensation: US$182.43k

Board Members

  • John O'Bireck (61yo)

    Director

    • Tenure: 3.8yrs
  • Shawn Leon (60yo)

    Chairman

    • Tenure: 8.4yrs
    • Compensation: US$182.43k
  • Gerry Miller (62yo)

    Director

    • Tenure: 3.8yrs

Company Information

Ethema Health Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ethema Health Corporation
  • Ticker: GRST
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$8.046m
  • Shares outstanding: 146.30m
  • Website: https://ethemahealth.com

Number of Employees


Location

  • Ethema Health Corporation
  • 810 Andrews Avenue
  • Delray Beach
  • Florida
  • 33483
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GRSTOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2001

Biography

Ethema Health Corporation, together with its subsidiaries, operates substance abuse treatment center. It operates Addiction Recovery Institute of America in West Palm Beach, Florida. The company was former ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 23:44
End of Day Share Price2019/09/12 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.